Reported figures and Equlion model projections for the next 5 years.
ROE
-13.3 pt
Company
ROA
-6.6 pt
Company
Gross Margin
-8.9 pt
Company
Sector average
Net Margin
-5.3 pt
Company
Total Assets
+47%
Company
Sector average
Net Income
-343.8%
Company
Valuation
-20.6%
Company
Sector average (own scale)
Stock Price
-20.6%
Company
Sector average (own scale)
Amounts in KRW; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Ahn-Gook Pharmaceutical Co., Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.